105 related articles for article (PubMed ID: 16174231)
21. [Treatment of brain metastasis from ovarian cancer].
Bondiau PY; Largillier R; Foa C; Rasendrarijao D; Frenay M; Gérard JP
Cancer Radiother; 2003 Jun; 7(3):184-6. PubMed ID: 12834774
[TBL] [Abstract][Full Text] [Related]
22. Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19).
Marchetti C; Ferrandina G; Cormio G; Gambino A; Cecere S; Lorusso D; De Giorgi U; Bogliolo S; Fagotti A; Mammoliti S; Narducci F; Bergamini A; Scollo P; Biglia N; Breda E; Tamberi S; Marinaccio M; Angioli R; Salerno L; Eusebi MC; Loizzi V; Scambia G; Panici PB
Gynecol Oncol; 2016 Dec; 143(3):532-538. PubMed ID: 27717490
[TBL] [Abstract][Full Text] [Related]
23. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer.
Shen Y; Li L
Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144
[TBL] [Abstract][Full Text] [Related]
24. Treatment Results and Prognostic Factors of Brain Metastases From Ovarian Cancer: A Single Institutional Experience of 56 Patients.
Kwon JW; Yoon JH; Lim MC; Joo J; Yoo H; Shin SH; Park SY; Lee SH; Kim YJ; Kim JY; Gwak HS
Int J Gynecol Cancer; 2018 Oct; 28(8):1631-1638. PubMed ID: 30247251
[TBL] [Abstract][Full Text] [Related]
25. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
26. [Clinical analysis of 23 gynecologic carcinoma patients with brain metastasis].
Zhang JX; Wang SZ; Li B; Zhang ZY
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(23):1843-6. PubMed ID: 27356795
[TBL] [Abstract][Full Text] [Related]
27. Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy.
Han LY; Karavasilis V; Hagen Tv; Nicum S; Thomas K; Harrison M; Papadopoulos P; Blake P; Barton DP; Gore M; Kaye SB
Eur J Cancer; 2010 May; 46(8):1359-64. PubMed ID: 20303743
[TBL] [Abstract][Full Text] [Related]
28. Gamma Knife Surgery for Metastatic Brain Tumors from Gynecologic Cancer.
Matsunaga S; Shuto T; Sato M
World Neurosurg; 2016 May; 89():455-63. PubMed ID: 26844877
[TBL] [Abstract][Full Text] [Related]
29. Brain metastasis of ovarian epithelial carcinoma.
Sun HD; Chao KC; Shen SH; Lai CR; Twu NF; Yuan CC; Yen MS; Wu HH; Chen YJ
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):101-4. PubMed ID: 20466304
[No Abstract] [Full Text] [Related]
30. Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial).
Nasu K; Satoh T; Nishio S; Nagai Y; Ito K; Otsuki T; Hongo A; Hirashima Y; Ogura T; Shimada M
Gynecol Oncol; 2013 Feb; 128(2):198-203. PubMed ID: 23142074
[TBL] [Abstract][Full Text] [Related]
31. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
Juretzka MM; Barakat RR; Chi DS; Iasonos A; Dupont J; Abu-Rustum NR; Poynor EA; Aghajanian C; Spriggs D; Hensley ML; Sabbatini P
Gynecol Oncol; 2007 Jan; 104(1):176-80. PubMed ID: 16996584
[TBL] [Abstract][Full Text] [Related]
32. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
[TBL] [Abstract][Full Text] [Related]
33. Laparoscopic splenectomy for solitary splenic metastasis in a patient with ovarian cancer with a long disease-free interval: a case report.
Yasuda K; Yoshimura T; Kitade H; Yanagida H; Hosaka N
J Med Case Rep; 2018 May; 12(1):132. PubMed ID: 29759073
[TBL] [Abstract][Full Text] [Related]
34. The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
Le T; Hopkins L; Faught W; Fung-Kee-Fung M
Gynecol Oncol; 2007 Jun; 105(3):712-5. PubMed ID: 17400284
[TBL] [Abstract][Full Text] [Related]
35. Brain metastasis in pediatric extracranial solid tumors: survey and literature review.
Kebudi R; Ayan I; Görgün O; Ağaoğlu FY; Vural S; Darendeliler E
J Neurooncol; 2005 Jan; 71(1):43-8. PubMed ID: 15719274
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival in an ovarian cancer patient with brain metastases.
Micha JP; Goldstein BH; Hunter JV; Rettenmaier MA; Brown JV
Gynecol Oncol; 2004 Mar; 92(3):978-80. PubMed ID: 14984970
[TBL] [Abstract][Full Text] [Related]
37. CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use.
Duffy MJ; Bonfrer JM; Kulpa J; Rustin GJ; Soletormos G; Torre GC; Tuxen MK; Zwirner M
Int J Gynecol Cancer; 2005; 15(5):679-91. PubMed ID: 16174214
[TBL] [Abstract][Full Text] [Related]
38. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
[TBL] [Abstract][Full Text] [Related]
39. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
40. Solitary cerebral metastasis from ovarian carcinoma: report of 4 cases.
Salvati M; Cervoni L
J Neurooncol; 1994; 19(1):75-7. PubMed ID: 7815107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
